{"id":61424,"date":"2025-06-13T22:02:35","date_gmt":"2025-06-13T20:02:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/breast-cancer-canada-applauds-federal-commitment-to-modernize-preventive-health-guidelines\/"},"modified":"2025-06-13T22:02:35","modified_gmt":"2025-06-13T20:02:35","slug":"breast-cancer-canada-applauds-federal-commitment-to-modernize-preventive-health-guidelines","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/breast-cancer-canada-applauds-federal-commitment-to-modernize-preventive-health-guidelines\/","title":{"rendered":"Breast Cancer Canada Applauds Federal Commitment to Modernize Preventive Health Guidelines"},"content":{"rendered":"
\n

\nInclusion of experts, patient voices, and equity-focused policy reflects priorities long championed by Breast Cancer Canada<\/i><\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

TORONTO–(BUSINESS WIRE)–Breast Cancer Canada proudly celebrates the federal government\u2019s response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care<\/a>, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is more equitable, expert-informed, and responsive to real-world care.<\/p>\n

\n\u201cThese systematic changes will save lives,\u201d said Kimberly Carson, CEO of Breast Cancer Canada. \u201cWe commend Canada\u2019s Federal Health Minister Marjorie Michel for making this a priority so early in her mandate, and we thank former Health Minister Mark Holland for working so closely with Breast Cancer Canada during his tenure. This milestone reflects years of dedicated advocacy. Bringing expert voices into task force decision-making is a long-overdue step toward ensuring that both science and lived experience shape public policy for Canadians.\u201d<\/p>\n

\nThe EER outlines recommendations, including stronger integration of subject matter experts, patient and public voices, and structured provincial input in guideline development. For Breast Cancer Canada and the REAL Canadian Breast Cancer Alliance\u2014a national coalition of breast cancer experts\u2014the report validates their persistent calls to reform how health guidance is developed and delivered in Canada. It also affirms that advocacy works: the federal government listened to patients and advocates calling for change.<\/p>\n

\nThis report embodies the transformative shift Breast Cancer Canada has relentlessly advocated for: expert-led, patient-centred, and equity-driven care informed by Canadian data and research. It signals a new era in Canadian breast cancer policy, one grounded in a national commitment to access for all.<\/p>\n

\n\u201cThis report is a breakthrough,\u201d said Kimberly Carson, CEO of Breast Cancer Canada. \u201cIt recognizes that science and lived experience must work together to shape public health guidance. These recommendations reflect what Breast Cancer Canada, researchers, clinicians, and patients have been saying for years.\u201d<\/p>\n

\nFounded by Breast Cancer Canada in 2023, REAL Canadian Breast Cancer Alliance brings together leading clinicians, patient advocates and data from across the country to advance evidence-based, equitable, and patient-informed breast cancer care. REAL Alliance was established to ensure that the latest research reaches patients faster and to help establish equitable, national standards of care for breast cancer.<\/p>\n

\nBreast Cancer Canada is actively addressing the critical gap in Canadian-specific data by collecting and analyzing breast cancer outcomes across all stages and subtypes, with a focus on race, age, and geographic location.<\/p>\n

\n\u201cWe are especially encouraged to see a formal shift toward expert engagement,\u201d said Shaniah Leduc, Chair of Breast Cancer Canada\u2019s Board of Directors. \u201cGuidelines that impact patient outcomes must include disease-specific expertise. It\u2019s not just about input\u2014it\u2019s about equity and access. Science moves quickly, and lives are affected when guidelines lag behind. A commitment to living guidelines ensures Canadians benefit from the most current knowledge in real-time.\u201d<\/p>\n

\n\u201cAs someone whose survival depended on timely diagnosis and access to targeted treatment, I know firsthand the power of evidence-based care,\u201d said Kim MacDonald, breast cancer survivor and advocate with Breast Cancer Canada. \u201cThe recommendations released today are long overdue. Including expert insight and patient experience in national health guidance isn\u2019t just the right thing to do\u2014it\u2019s what saves lives. My story could have ended differently without access to the testing and treatment I needed. Every Canadian deserves equity and access.\u201d<\/p>\n

\nAs the report notes, current guideline development in Canada is fragmented and often lacks the flexibility to reflect provincial realities or incorporate diverse forms of knowledge. The recommendations call for a pan-Canadian coordination hub and better integration with provincial screening programs, quality councils, and implementation bodies.<\/p>\n

\n\u201cWhen evidence, expert insight, and lived experience come together, patients benefit,\u201d Carson added. \u201cWe look forward to seeing these recommendations put into action and continuing our role in ensuring breast cancer care is equitable, evidence-based, and patient-informed.\u201d<\/p>\n

\nKey Takeaways from the External Expert Review of Canada\u2019s Preventive Health Guidelines:<\/b><\/p>\n